US BANCORP \DE\ - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$114,786
+104.5%
2,990
+1.0%
0.00%
Q2 2023$56,132
+20.6%
2,959
-1.4%
0.00%
Q1 2023$46,561
-11.3%
3,002
+1.5%
0.00%
Q4 2022$52,522
+556.5%
2,959
+114.9%
0.00%
Q3 2022$8,000
+166.7%
1,377
+113.2%
0.00%
Q2 2022$3,0000.0%646
+1.7%
0.00%
Q1 2022$3,000
-62.5%
635
-32.2%
0.00%
Q4 2021$8,000
-11.1%
937
-10.9%
0.00%
Q3 2021$9,0001,0520.00%
Other shareholders
IMMUNOVANT INC shareholders Q1 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders